$AURX .20?! ONLY 1.8 MILLION FLOAT!NOT-A-MISPRINT WHY DO INSIDERS OWN OVER 70% OF SHARES? UNKNOWN to 99.99999% of traders, moves on a air on a power scale less than a whisper #BIOTECH GEM. 6 INSIDERS just ADDED SHARES per the 7 January 3rd filings and I'm the only trader that knows (I guess)!!!!? 6 Form 4 filing silently out, NO ONE NOTICED. WHY?????? Last time I alerted it at .05 it ran to .575 in 5 days. Nothing has changed since then...oh wait 1 thing has changed, INSIDERS BOUGHT MORE SHARESSSSSS!
David Jorden: Peter Clausen:
Eric Winzer: Scott Pittman: Lawrence Atinsky: Paul Mintz: ALL 6 just LOADED!! Exercise price ...wait for it... 40 CENTS!!! Shhhhh.
AURX is THE FIRST platelet & plasma therapy system TO BE CLEARED by the FDA for the management of ulcers & wounds of all types & all severities? https://t.co/yPfwfHL1V8????
Private placement at 30 cents and traders are ignoring this at 20 cents?! I'm compelled to ask myself do I have super vision or is everyone else using a Navigation system created by the 3 blind mice? What more can i say? I'm trying to keep it do simple a 4 year old could understand it.
$AURX why did SHEEDY CHARLES E purchase 5.2 million shares at 22 cents (that's over $1.1 million folks) to add to the 3 million he already owned? He graduated from Harvard Business school so trust me he has a LITTLE smarts, maybe a tiny bit of intelligence.
https://t.co/vI58wsa8W8
why did Boyalife Investment Fund I, Inc just purchase 3.1 million shares at .22 (DO THE MATH) #biotech gem #stocks #stockmarket #stocktrading #BTC
The only thing common about common sense is that it's UNCOMMON.
https://www.otcmarkets.com/stock/AURX/disclosure
Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Gaithersburg, Maryland.
AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX AURX
Recent AURX News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:26:06 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 05/22/2024 04:40:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 07:13:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 07:11:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 12:30:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:00:47 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 06:58:57 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:33:36 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/20/2023 07:18:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 07:04:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 07:03:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 02:02:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:30:31 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 02:37:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:18:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:17:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:15:23 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM